Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (als) is a neurodegenerative disorder characterised by progressive muscle weakness that can start in limb, axial, bulbar, or respiratory muscles and then generalises. Sep 27, 2024amyotrophic lateral sclerosis (als) is a neurodegenerative disorder characterized by progressive muscle weakness that can start in limb, axial, bulbar, or respiratory muscles and then. Sep 4, 2025a blood test that reliably identifies amyotrophic lateral sclerosis years before symptoms appear offers new hope for earlier diagnosis of the disease.

Oct 7, 2025amyotrophic lateral sclerosis may involve an autoimmune component — a finding that could reshape treatment strategies and lead to new tools for predicting disease course. Jun 30, 2025a meta-analysis shows moderate evidence that respiratory muscle training improves lung function, particularly respiratory muscle strength, in patients with amyotrophic lateral sclerosis. Feb 24, 2025the first platform trial for amyotrophic lateral sclerosis (als), which individually evaluated four experimental drugs, failed to meet key primary endpoints.

Oct 18, 2024ema re-evaluated data for masitinib for the treatment of amyotrophic lateral sclerosis and translarna for duchenne, confirming its initial refusals. Prescribed use of anxiolytics, hypnotics and sedatives, or antidepressants was associated with a significantly increased risk for future development of amyotrophic lateral sclerosis. Feb 23, 2024treatments for amyotrophic lateral sclerosis and paroxysmal nocturnal hemoglobinuria have been given marketing authorization by the european medicines agency.

Aug 15, 2024an advanced brain-computer interface (bci) that can translate brain signals into speech with up to 97% accuracy, has restored the speech of a man with amyotrophic lateral sclerosis (als).